EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Zosano Pharma's enterprise value is $-7.49 Mil.
Zosano Pharma's Revenue for the trailing twelve months (TTM) ended in Mar. 2022 was $0.66 Mil. Therefore, Zosano Pharma's EV-to-Revenue for today is -11.36.
The historical rank and industry rank for Zosano Pharma's EV-to-Revenue or its related term are showing as below:
ZSANQ's EV-to-Revenue is not ranked *
in the Biotechnology industry.
Industry Median: 8.115 * Ranked among companies with meaningful EV-to-Revenue only.
As of today (2024-05-28), Zosano Pharma's stock price is $0.0002.
Zosano Pharma's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2022 was $0.19. Therefore, Zosano Pharma's PS Ratio for today is 0.00.
Zosano Pharma EV-to-Revenue Historical Data
The historical data trend for Zosano Pharma's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Zosano Pharma's EV-to-Revenue
For the Biotechnology subindustry, Zosano Pharma's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zosano Pharma's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Zosano Pharma's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Zosano Pharma's EV-to-Revenue falls into.
Zosano Pharma's current Enterprise Value is $-7.49 Mil.
Zosano Pharma's Revenue for the trailing twelve months (TTM) ended in Mar. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.66 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zosano Pharma's share price for today is $0.0002.
Zosano Pharma's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.19.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zosano Pharma EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Zosano Pharma's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Zosano Pharma (Zosano Pharma) Business Description
Zosano Pharma Corp is a clinical-stage biopharmaceutical company. It is focused on providing rapid systemic administration of therapeutics and other bioactive molecules to patients using the proprietary transdermal microneedle system. The system is designed to facilitate rapid drug absorption into the bloodstream, which can result in an improved pharmacokinetic profile compared to original dosage forms. The company's operating segment is to develop human pharmaceutical products. Its primary product candidate is Qtrypta (M207) which is the proprietary formulation of zolmitriptan delivered utilizing the system.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ZSANQ has been successfully added to your 